GNTA — Genenta Science SpA Cashflow Statement
0.000.00%
Last trade - 00:00- $145.22m
- $130.92m
- 28
- 14
- 52
- 22
Annual cashflow statement for Genenta Science SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.59 | -5.53 | -8.48 | -11.6 | -8.91 |
| Depreciation | |||||
| Non-Cash Items | 0.466 | 0.51 | 0.813 | 0.816 | 0.91 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.921 | -1.94 | 0.24 | -0.418 | 1.72 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.04 | -6.96 | -7.42 | -11.2 | -6.24 |
| Capital Expenditures | -0.021 | -0.009 | -0.027 | -0.014 | -0.004 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -14.9 | 6.89 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.021 | -0.009 | -0.027 | -14.9 | 6.88 |
| Financing Cash Flow Items | -0.111 | 0 | 0 | 0.001 | 0.271 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 1.39 | 28.7 | 0 | 0.001 | 0.271 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.68 | 21.8 | -7.45 | -26.1 | 0.89 |